📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Serum levels of hsa-miR-16-5p , hsa-miR-29a-3p , hsa-miR-150-5p , hsa-miR-155-5p and hsa-miR - 223-3p and subsequent risk of chronic lymphocytic leukemia in the EPIC study (2020)

First Author: Casabonne D

Attributed to: The EPIC-Norfolk prospective population study: biological and behavioural determinants of health and disease in an ageing population funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/ijc.32894

PubMed Identifier: 32012253

Publication URI: http://europepmc.org/abstract/MED/32012253

Type: Journal Article/Review

Parent Publication: International Journal of Cancer

Issue: 5

ISSN: 0020-7136